A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease

Bingjie Xie, Fankai Lin, Kaleem Ullah, Lei Peng, Wei Ding, Rongji Dai, Hong Qing, Yulin Deng*

*此作品的通讯作者

科研成果: 期刊稿件文章同行评审

36 引用 (Scopus)
Plum Print visual indicator of research metrics
  • Citations
    • Citation Indexes: 36
  • Captures
    • Readers: 39
see details

摘要

Background Diabetes is associated with an increased risk of Parkinson's disease (PD). Number of studies have suggested that methylglyoxal (MGO) induced by diabetes is related to PD. However, very little is known about its molecular mechanism. On other hand, 1-acetyl-6, 7- dihydroxyl-1, 2, 3, 4- Tetrahydroisoquinoline(ADTIQ) is a dopamine (DA)-derived tetrahydroisoquinoline (TIQ), a novel endogenous neurotoxins, which was first discovered in frozen Parkinson's disease human brain tissue. While ADTIQ precursor methylglyoxal was also found in diabetic patients related to the glucose metabolism and diabetic patients. Methods LC-MS/MS, 1H NMR and infrared spectroscopy identified the structure of ADTIQ. The Annexin V-FITC/PI, MTT and western blot analysis were used to measure the neurotoxicity of ADTIQ. The levels of ADTIQ and methylglyoxal were detected by LC-MS/MS. Results Here we report the chemical synthesis of ADTIQ, demonstrate its biosynthesis in SH-SY5Y neuroblastoma cell line and investigate its role in the pathogenesis of PD. In addition, a significant increase in the level of ADTIQ was detected in the brains of transgenic mice expressing mutant forms (A53T or A30P) of α-synuclein. ADTIQ also reduced the cell viability and induced mitochondrial apoptosis in dopaminergic cells, suggesting that ADTIQ acts as an endogenous neurotoxin and potentially involved in the pathogenesis of PD. Methylglyoxal, a major byproduct of glucose metabolism and abnormalities in glucose metabolism could influence the levels of ADTIQ. Consistent with the hypothesis, increased levels of ADTIQ and methylglyoxal were detected in the striatum of diabetic rats and SH-SY5Y cells cultured in the presence of high glucose concentrations. Conclusions Increased levels of ADTIQ could be related with Hyperglycemia and death of dopaminergic neurons. General significance The increased levels of ADTIQ could be a reason of dopamine neuron dysfunction in diabetes. Therefore, ADTIQ may play a key role in increasing the risk for PD in patients with diabetes.

源语言英语
页(从-至)361-366
页数6
期刊Biochemical and Biophysical Research Communications
459
3
DOI
出版状态已出版 - 10 4月 2015

指纹

探究 'A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease' 的科研主题。它们共同构成独一无二的指纹。

引用此

Xie, B., Lin, F., Ullah, K., Peng, L., Ding, W., Dai, R., Qing, H., & Deng, Y. (2015). A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease. Biochemical and Biophysical Research Communications, 459(3), 361-366. https://doi.org/10.1016/j.bbrc.2015.02.069